Jiaqi Liang Selected Research

Jiaqi Liang Research Topics

Disease

26	Neoplasms (Cancer) 11/2022 - 04/2016
11	Adenocarcinoma of Lung 11/2022 - 01/2020
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2022 - 12/2019
3	Carcinogenesis 01/2021 - 01/2020
2	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2019
2	Carcinoma (Carcinomatosis) 01/2021 - 12/2019
2	Inflammation (Inflammations) 01/2020 - 01/2019
1	Microsatellite Instability 03/2022
1	Colorectal Neoplasms (Colorectal Cancer) 03/2022
1	Esophageal Squamous Cell Carcinoma 01/2022
1	Hypoxia (Hypoxemia) 01/2022
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2022
1	Malaria 12/2021
1	Angina Pectoris 12/2021
1	Infections 11/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2020
1	Bloom Syndrome 06/2020
1	Endotoxemia 01/2020
1	Adenocarcinoma 01/2020
1	Hypersensitivity (Allergy) 01/2020
1	Septic Shock (Toxic Shock Syndrome) 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Sepsis (Septicemia) 01/2020
1	Insulin Resistance 12/2019
1	Type 2 Diabetes Mellitus (MODY) 12/2019
1	Vascular Remodeling 11/2019
1	Stomach Neoplasms (Stomach Cancer) 10/2019
1	Hypertension (High Blood Pressure) 04/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Thrombosis (Thrombus) 01/2019
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2017
1	Japanese Encephalitis 01/2017

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 03/2022 - 04/2016
8	Biomarkers (Surrogate Marker)IBA 03/2022 - 06/2020
7	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2016
6	Pharmaceutical PreparationsIBA 01/2022 - 12/2019
5	MicroRNAs (MicroRNA)IBA 04/2021 - 08/2020
4	Small Cytoplasmic RNAIBA 07/2021 - 01/2020
3	LigandsIBA 03/2022 - 01/2020
3	Biological ProductsIBA 01/2021 - 04/2016
2	Cisplatin (Platino)FDA LinkGeneric 11/2022 - 06/2022
2	Metformin (Glucophage)FDA LinkGeneric 07/2022 - 01/2022
2	Pemetrexed (MTA)FDA Link 06/2022 - 12/2019
2	IronIBA 01/2022 - 01/2021
2	Glucose (Dextrose)FDA LinkGeneric 12/2021 - 12/2019
2	Messenger RNA (mRNA)IBA 11/2021 - 06/2020
2	Nonprescription Drugs (Patent Medicines)IBA 12/2019 - 04/2019
2	DNA (Deoxyribonucleic Acid)IBA 12/2019 - 01/2017
1	PlatinumIBA 11/2022
1	Immune Checkpoint InhibitorsIBA 07/2022
1	Cancer VaccinesIBA 07/2022
1	atezolizumabIBA 07/2022
1	HMPL-013IBA 03/2022
1	sintilimabIBA 03/2022
1	Biocompatible Materials (Biomaterials)IBA 01/2022
1	Fibroins (Fibroin)IBA 01/2022
1	Long Noncoding RNAIBA 01/2022
1	CytosineIBA 12/2021
1	Transfer RNA (tRNA)IBA 12/2021
1	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2021
1	HMGB1 Protein (HMG1)IBA 11/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	NivolumabIBA 08/2020
1	ErbB Receptors (EGF Receptor)IBA 08/2020
1	durvalumabIBA 08/2020
1	Histones (Histone)IBA 06/2020
1	CDC2 Protein Kinase (Protein p34cdc2)IBA 06/2020
1	RecQ HelicasesIBA 06/2020
1	Cyclin B1IBA 06/2020
1	LipopolysaccharidesIBA 01/2020
1	Toll-Like Receptor 4IBA 01/2020
1	CaspasesIBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	SuspensionsIBA 01/2020
1	Folic Acid AntagonistsIBA 12/2019
1	Lactic Acid (Lactate)FDA LinkGeneric 12/2019
1	GlycolipidsIBA 12/2019
1	TabletsIBA 12/2019
1	Citric Acid (Citrate)FDA LinkGeneric 12/2019
1	Oncogene Proteins (Oncogene Protein)IBA 12/2019
1	JinqiIBA 12/2019
1	Pyruvic Acid (Pyruvate)IBA 12/2019
1	Semaphorins (Semaphorin)IBA 10/2019
1	songling xuemaikangIBA 04/2019
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2019
1	trimethyloxamine (trimethylamine N-oxide)IBA 01/2019
1	CholesterolIBA 01/2019
1	VaccinesIBA 01/2017
1	Nucleic AcidsIBA 04/2016

Therapy/Procedure

8	Therapeutics 07/2022 - 04/2016
7	Immunotherapy 07/2022 - 01/2020
5	Drug Therapy (Chemotherapy) 11/2022 - 05/2020
1	Injections 01/2022
1	Microspheres (Microsphere) 01/2022
1	Aftercare (After-Treatment) 12/2021
1	Neoadjuvant Therapy 06/2020
1	Adjuvant Chemoradiotherapy 06/2020
1	Complementary Therapies (Alternative Medicine) 04/2019
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 04/2019